Dual-Eligible Patients Fall Through the Cracks in Substance Use Disorder Treatment

Key Takeaways

• 12 million Americans are dual‑eligible for Medicare and Medicaid
• 1.5 million dual‑eligible beneficiaries have a substance‑use disorder
• Medicaid covers roughly half of recommended SUD services, state‑by‑state
• Medicare’s new outpatient benefits exclude telehealth, leaving many rural areas uncovered
• Align coverage, remove prior authorizations, and boost D‑SNP SUD accountability

Pulse Analysis

The dual‑eligible population represents a concentrated nexus of chronic illness, mental health challenges, and financial risk. With 12 million people straddling Medicare and Medicaid, they are disproportionately affected by substance‑use disorders—about 1.5 million carry a diagnosis. Yet the two programs operate in silos, leaving patients to navigate separate benefit structures that often fail to meet clinical guidelines for a full continuum of care. This structural disconnect translates into fragmented treatment pathways, higher emergency‑department visits, and avoidable inpatient stays, inflating costs for both federal programs.

Medicaid, the primary payer for SUD services, currently funds roughly half of the treatments recommended by the American Society of Addiction Medicine, and coverage varies widely across states. Prior‑authorization hurdles, visit caps, and low reimbursement rates further deter providers, especially in rural areas where provider networks are thin. Medicare’s 2024 expansion of intensive outpatient services is a step forward, but it excludes telehealth and relies on local opioid treatment programs—absent in over 1,000 counties—leaving many beneficiaries without viable options. The combined effect is a treatment desert that pushes patients toward crisis‑driven care rather than sustained, evidence‑based interventions.

Policymakers have clear levers to address these deficiencies. Setting federal minimum standards tied to clinical guidelines would harmonize Medicaid coverage and ensure Medicare expands to intermediate and residential levels of care, including virtual delivery models. Reducing prior‑authorization requirements and enforcing parity laws can accelerate access, while strengthening accountability for Dual‑Eligible Special Needs Plans with SUD‑specific quality metrics could improve coordination. Closing these gaps promises better health outcomes, reduced acute‑care spending, and a more efficient safety‑net for the nation’s most vulnerable patients.